Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study

Background: Our previous study reported that histamine H2 receptor antagonists (H2RAs) exposure was associated with decreased mortality in critically ill patients with heart failure (HF) through the same pharmacological mechanism as β-blockers. However, population-based clinical study directly compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xue-Sha, Cai, Wen-Ke, Wang, Ping, Xu, Ran, Yin, Sun-Jun, Huang, Yan-Hua, Guo, Yu, Jiang, Fang-Fang, Pan, Jian-Mei, Li, Yi-Hua, He, Gong-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683642/
https://www.ncbi.nlm.nih.gov/pubmed/38035020
http://dx.doi.org/10.3389/fphar.2023.1273640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683642/
https://www.ncbi.nlm.nih.gov/pubmed/38035020
http://dx.doi.org/10.3389/fphar.2023.1273640

Ejemplares similares